Children and young people with advanced cancer frequently have a central venous access device (central line) in place which can be used for intravenous medication...
It is becoming common practice for children with acute lymphoblastic leukaemia to receive the chemotherapy agent intravenous cytosine arabinoside (cytarabine, ara...
